Quantcast

Latest Cancer Stories

2014-08-26 08:31:11

Recognized as Leader for Groundbreaking Work in Cancer Diagnostics REDWOOD CITY, Calif., Aug. 26, 2014 /PRNewswire/ -- Guardant Health, a healthcare company focused on the development and commercialization of oncology diagnostic products, has been recognized today by the World Economic Forum as a 2015 Technology Pioneer. As an innovator in non-invasive, tumor profiling, Guardant Health is one of 24 companies across a wide variety of industries and regions to receive this prestigious...

2014-08-25 23:00:32

HealthForumOnline (HFO) announces recent updates to its online continuing education (CE) course, Response to Medical Illness: A Clinical Perspective on Trauma and Posttraumatic Growth - providing psychologisst, social workers, counselors and allied health professionals with theory- and evidence-based strategies to help patients cope with health-related trauma and promote psychological resilience to acute and/or chronic medical conditions. HFO offers over 95 online nationally-approved (APA,...

2014-08-25 12:26:10

ELKO, Nev., Aug. 25, 2014 /PRNewswire/ -- Dr. Douglas Debenham, board certified radiation oncologist, has announced plans to build a new radiation oncology center in Elko, Nevada this year. The new Northeastern Nevada Radiation Oncology Center will be fully operational and treating patients by the first quarter of 2015, thanks to a partnership between RBS Evolution (RBSE), a provider of cancer treatment centers in underserved communities, and Northeastern Nevada Regional Hospital,...

2014-08-25 12:26:05

Contract Results from Recent Merger with MabVax Therapeutics, Inc. SAN DIEGO, Aug. 25, 2014 /PRNewswire/ -- Telik, Inc. (OTCQB: TELK), a clinical stage oncology drug development company that merged with MabVax Therapeutics, Inc. on July 8, 2014, announced today it has received a $1.5 million contract for the Phase 2 portion of a Small Business Innovation Research (SBIR) contract from the National Cancer Institute (NCI). The contract is intended to support a major portion of the...

2014-08-25 08:28:14

WOONSOCKET, R.I., Aug. 25, 2014 /PRNewswire/ -- MultiCell Technologies, Inc. (OTC: MCET) has been issued U.S. patent 8,809,290 covering novel drug compositions and platform technologies which redirect the immune system response to protect against highly virulent virus infection and cancer. These novel drug compositions consisting of noncoding doubled stranded RNA (dsRNA) molecules and recombinant immunoglobulin-peptide (IgP) molecules demonstrate unique immune stimulating activity,...

2014-08-25 08:27:12

Initial Closing is for $10 Million FREDERICK, Md., Aug. 25, 2014 /PRNewswire/ -- Vaccinogen, Inc., (OTC.QB: VGEN) a cancer immunotherapy development company, announced today that it completed the initial closing of a private placement of $80 million of units and common stock. Vaccinogen received gross proceeds of $10 million in this first closing. http://photos.prnewswire.com/prnvar/20140825/139089 Vaccinogen is preparing to start ACTIVE, a confirmatory Phase IIIb pivotal...

botox for gastric cancer
2014-08-23 05:56:29

Eric Hopton for redOrbit.com - Your Universe Online Botox is in the news again, and this time it looks like potentially good news for some cancer treatments. Although it still receives mixed reviews as a result of its association with cosmetic procedures and some high-profile failures, the medical world is discovering new ways in which Botox can help treat a wide range of conditions. In a new process which has been described as “cheap, safe and efficient,” researchers have found...

2014-08-22 04:21:25

LUGANO, Switzerland, August 22, 2014 /PRNewswire/ -- The European Society for Medical Oncology (ESMO), the leading pan-European organisation representing medical oncologists, announced the names of outstanding individuals receiving the Society's esteemed annual awards, to be presented during the ESMO 2014 Congress, on 26 September, in Madrid. Carsten Bokemeyer will receive the ESMO Award...

2014-08-21 23:16:22

Gallus BioPharmaceuticals, LLC, a premier, full service biopharmaceutical contract development and manufacturing organization announced today that it has been selected by Progenics Pharmaceuticals, Inc., an oncology company focused on the development of innovative approaches to targeting and treating cancer, to manufacture the anti-prostate specific membrane antigen (PSMA) monoclonal antibody used in Progenics’ PSMA ADC product candidate. St. Louis, MO (PRWEB) August 21, 2014 Gallus...

2014-08-21 23:15:41

Lesscancer.org Board member Margaret I. Cuomo, M. D. is a member of New York State Comprehensive Cancer Control Plan. (PRWEB) August 21, 2014 Next Generation Choices Foundation, more widely known as Lesscancer.org, is pleased to announce the launch of the New York State Comprehensive Cancer Control Plan Dashboard (the Dashboard) in partnership with the New York State Cancer Consortium (the Consortium). The Consortium is a network of individuals and organizations that collaborate to...


Latest Cancer Reference Libraries

British Journal of Cancer
2012-05-28 10:11:32

The British Journal of Cancer (BJC) is a professional medical journal published biweekly by the Nature Publishing Group (a division of Macmillan Publishers Ltd.) on behalf of Cancer Research UK. It provides a forum for clinicians and scientists to communicate original research findings that have relevance to understanding the etiology of cancer and to improving patient treatment and survival. Papers are published both in print and online. The journal publishes full research papers and...

45_16476fe85b6c94ca2cddefe0d4dea632
2011-02-17 16:45:25

Merkel cell polyomavirus (MCV or MCPyV), first discovered in January 2008, is one of seven human tumor viruses. It is suspected to cause most of Merkel cell carcinoma which is a rare, aggressive form of skin cancer. Around 80% of Merkel cell carcinoma tumors are found to be infected with MCV. It is found in respiratory secretions suggesting that it may be transmitted by a respiratory route. Usually the tumors with MCV viruses go through at least two mutations that render the virus...

0_d7e189bb6feb0f5663af7d072b6f51c6
2011-02-17 14:56:32

A human papillomavirus (HPV), a member of the papillomavirus family, is capable of infecting humans. HPVs establish productive infections in the skin or mucous membranes. Most of the 200 known types cause no symptoms in most people. Some types can cause warts, while others can lead to cancer. There are more than 30 to 40 types of HPV that are typically transmitted through sexual contact and infect the anogenital region. High risk HPV, can lead to cancer, in fact HPV infection is a cause of...

28_2d79dc61ecefd3449819abf298f2554d
2005-05-26 12:16:31

Asbestos (Greek a-, "not"; sbestos, "extinguishable") is a group of fibrous metamorphic minerals. The name is derived for its historical use in lamp wicks; the resistance of asbestos to fire has long been exploited for a variety of purposes. It was used in fabrics such as Egyptian burial cloths and Charlemagne's tablecloth, which, according to legend, he threw in a fire to clean. When asbestos is used for its resistance to fire or heat, the fibers are typically mixed with cement or woven...

3_ee7b9bf5a8a73941accea20822106ac22
2004-10-19 04:45:40

Cancer Constellation -- The constellation Cancer, the crab, is known in astronomy and astrology as one of the twelve constellations of the zodiac. Cancer is small and dim, and does not resemble a crab. It lies between Gemini to the west and Leo to the east, Lynx to the north and Canis Minor and Hydra to the south. Notable features The brightest star in Cancer is β Cancri, called Al Tarf ("the end" of the crab's leg). Other stars include Acubens (α), and the Aselli (the...

More Articles (5 articles) »
Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related